Results 101 to 110 of about 3,514 (173)

Risk factors for drug-related gastrointestinal ulcer:a retrospective pharmacovigilance study. [PDF]

Front Pharmacol
Jiang S, Wang M, Ren X, Jiang Z, Zhu Q, Dai S, Li J, Zhao Z, Han L.   +8 more
europepmc   +1 more source

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]

World J Nephrol
Ilkun O, Jazayeri F, Kazory A.
europepmc   +1 more source

Evanescent extraosseous calcifications in low turnover bone: management and outcomes: a case report. [PDF]

Front Nephrol
Hernandez-Pérez M, Enos D.
europepmc   +1 more source

Sevelamer inhibits the formation of cholesterol gallstones by modulating bile acid metabolism. [PDF]

Front Pharmacol
Shen S, Ning M, Li M, Qian S, Ye X, Zhuang Q, Wu S, Wan X, Dong Z.   +8 more
europepmc   +1 more source

A STUDY ON HYPERPHOSPHATEMIA AND EFFECT OF SEVELAMER ON CARDIAC ENZYME LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS

, 2016
Objective: Chronic Kidney Disease (CKD) is characterized by progressive loss of kidney function over a period of time. Sevelamer hydrochloride is a phosphate binding agent used to control serum phosphate levels in End Stage Renal Disease (ESRD) patients ...
S., Senthil Kumar, K., Dhivya
core  

Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis. [PDF]

JBMR Plus
Dauchez A, Herrou J, Mihoubi-Bouvier F, Quartier P, Baujat G, Koumakis E, Briot K, Roux C.   +7 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Phosphorus-Lowering Drugs for CKD 3-5 Stages. [PDF]

Kidney Med
Hou W, Xie P, Fu Y, Wang C, Wang K, Sun Y, Wei W, Xu L, Su C.   +8 more
europepmc   +1 more source

Sevelamer-Associated Colitis as a Colon Cancer Mimicker. [PDF]

Gastro Hep Adv
Doll B, Shapiro C, Post Z, Al-Sabti R, Shariati F.   +4 more
europepmc   +1 more source

Sevelamer Ameliorates Early Cirrhosis and Inhibits Its Progression towards Hepatocellular Carcinoma in a Diethylnitrosamine-induced Rat Model. [PDF]

J Cancer Prev
Chen ZN, Lv YF, Liu ZX, Zhao R, Deng ZQ, Kang MD, Liao ZQ, Zhou FK, Liang QR, Tang Q.   +9 more
europepmc   +1 more source

Rare non-neoplastic gastrointestinal diseases-drugs and bugs. [PDF]

Pathologie (Heidelb)
Angerer L, Zauner T, Langer R.
europepmc   +1 more source